BPG is committed to discovery and dissemination of knowledge
Prospective Study
©The Author(s) 2025.
World J Cardiol. Sep 26, 2025; 17(9): 110220
Published online Sep 26, 2025. doi: 10.4330/wjc.v17.i9.110220
Table 3 Primary and secondary endpoints of peripheral intervention
Primary endpoints
Male
Female
P value
Total fluoro time (minute)33.3 ± 25.426.9 ± 15.70.071
DAP (μGy × m2)16371.7 ± 28148.28916.7 ± 9855.10.005
Air kerma (mGy)661.2 ± 1198.5470.8 ± 511.60.11
Contrast (cc)114.2 ± 63.3105.4 ± 58.90.39
Secondary endpoints complications16 (23)20 (26)0.59
Major adverse limb event17 (24)10 (13)0.091
MI2 (3)1 (1)0.52
Stroke00
Hematoma3 (4)2 (3)0.59
Dissection/perforation 6 (8)12 (16)0.17
Acute kidney injury9 (13)14 (18)0.34
Repeat intervention/target lesion revascularization11 (15)8 (11)0.37
Death2 (3)2 (2)0.52


Write to the Help Desk